Overlooked, undervalued: Cornell research seeks to elevate home care workers

A multidisciplinary team of Cornell researchers is collaborating to elevate the value of home care workers while improving their working conditions and patient outcomes.

Five companies ‘graduate’ from Cornell incubators

As the pandemic pomp and COVID circumstances dissipate, Cornell’s McGovern Center and Praxis Center incubators graduated five startups, putting them on the road to success.

NYC exhibition features plight of the ninespotted lady beetle

The exhibition, “Extinct and Endangered,” opens June 22 in New York City and is based on the macrophotography of renowned artist Levon Biss.

Antibodies in breast milk help shape infants’ gut bacteria and immunity

A study suggests boosting “naturally-produced” antibodies in mothers may enhance infants’ immunity against bacterial pathogens that cause infectious gastrointestinal diseases.

NYC mayors, Cornell presidents celebrate 10 years of Cornell Tech

New York City mayors past and present attended a celebration of the 10th anniversary of Cornell Tech, the technology and engineering-focused campus that Cornell launched in 2012 with its academic partner, the Technion-Israel Institute of Technology.

Gift to establish Paul Rubacha Department of Real Estate

The Cornell Board of Trustees voted May 26 to approve the Paul Rubacha Department of Real Estate, to be managed between the College of Architecture, Art and Planning and the Cornell SC Johnson College of Business.

Considering trauma in tech design could benefit all users

Computing-related retraumatization can be lessened or avoided in a few low- or no-cost ways, according to research co-led by Nicola Dell and Tom Ristenpart of Cornell Tech and the Cornell Ann S. Bowers College of Computing and Information Science.

Immune therapy targets cells that cause leukemia relapse

Genetically engineered immune cells successfully target the specific cancer cells that may be responsible for relapse of acute myeloid leukemia, according to a preclinical study by investigators at Weill Cornell Medicine.

Study reveals potential therapies for aggressive lymphoma

The Weill Cornell Medicine research takes a step toward precision medicine for a type of cancer that disproportionately affects people with African ancestry, an underserved population.